Zobrazeno 1 - 8
of 8
pro vyhledávání: '"M. N. Needle"'
Autor:
P G, Fisher, M N, Needle, A, Cnaan, H, Zhao, J R, Geyer, P T, Molloy, J W, Goldwein, A B, Herman-Liu, P C, Phillips
Publikováno v:
Cancer. 83(3)
A trend toward the use of prolonged postoperative chemotherapy, with radiotherapy deferred until relapse, has emerged for very young children with malignant brain tumors. This study was undertaken to determine the failure patterns among infants who r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::87b9879fc8d460b8560888f103c575d9
https://pubmed.ncbi.nlm.nih.gov/9690551
https://pubmed.ncbi.nlm.nih.gov/9690551
Autor:
S M, Blaney, M N, Needle, A, Gillespie, J K, Sato, G H, Reaman, S L, Berg, P C, Adamson, M D, Krailo, W A, Bleyer, D G, Poplack, F M, Balis
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 4(2)
The antitumor activity of topotecan administered as a 72-h continuous i.v. infusion was evaluated in children with refractory neuroblastoma and sarcomas of soft tissue and bone. We also attempted to increase the dose intensity of topotecan by includi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c36ad0088dac9da8e0d93ce8c7bc6569
https://pubmed.ncbi.nlm.nih.gov/9516923
https://pubmed.ncbi.nlm.nih.gov/9516923
Autor:
H, Bertsch, S, Rudoler, M N, Needle, P, Malloy, L, Sutton, J, Belasco, A, Meadows, J, Goldwein
Publikováno v:
Medical and pediatric oncology. 30(2)
We reviewed all pediatric cases referred for emergent/urgent therapy (requiring treatment within 48 hours) to identify frequency, patterns of presentation, and efficacy of therapy. We defined five categories of emergent/urgent therapy based on irradi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::02719a0f5e22c7c05336255e704441bd
https://pubmed.ncbi.nlm.nih.gov/9403018
https://pubmed.ncbi.nlm.nih.gov/9403018
Autor:
M N, Needle, P T, Molloy, J R, Geyer, A, Herman-Liu, J B, Belasco, J W, Goldwein, L, Sutton, P C, Phillips
Publikováno v:
Medical and pediatric oncology. 29(1)
Pre-clinical data and adult experience suggests that topoisomerase targeted anti-cancer agents may be highly schedule dependent, and efficacy may improve with prolonged exposure. To investigate this hypothesis, 28 children with recurrent brain and so
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c02eb17a42e4f8b62faf6131cc5f1140
https://pubmed.ncbi.nlm.nih.gov/9142202
https://pubmed.ncbi.nlm.nih.gov/9142202
Publikováno v:
Medical and pediatric oncology. 29(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::738de61e89e5ebd4c04e9e95db70bc45
https://pubmed.ncbi.nlm.nih.gov/9142210
https://pubmed.ncbi.nlm.nih.gov/9142210
Autor:
R J, Packer, M, Prados, P, Phillips, H S, Nicholson, J M, Boyett, J, Goldwein, L B, Rorke, M N, Needle, L, Sutton, R A, Zimmerman, C R, Fitz, L G, Vezina, E, Etcubanas, J C, Wallenberg, G, Reaman, W, Wara
Publikováno v:
Cancer. 77(10)
Prognosis for the majority of children with brain stem gliomas is dismal. In previous studies, recombinant beta-interferon (r beta IF) has been shown to be effective for children with recurrent brain stem gliomas and may also act synergistically with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::acbae32a2366818091d0d2f86c2d30c8
https://pubmed.ncbi.nlm.nih.gov/8640684
https://pubmed.ncbi.nlm.nih.gov/8640684
Publikováno v:
Journal of Clinical Oncology. 23:4604-4604
4604 Background: Immunomodulatory drugs are compounds that originated via the deliberate structural modification of thalidomide. CC-5013 a derivative with enhanced immunological and anti-angiogenic...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68f40d8904f4e2b5611de8c768d8e16e
https://doi.org/10.1200/jco.2005.23.16_suppl.4604
https://doi.org/10.1200/jco.2005.23.16_suppl.4604
Autor:
Robert J. Mayer, E. Van Cutsem, Philip J. Stella, Philip J. Gold, H. J. Lenz, Allen Lee Cohn, N. Azarnia, B. Mirtsching, Andrew William Pippas, M. N. Needle
Publikováno v:
Journal of Clinical Oncology. 22:3510-3510
3510 Background: Cetuximab (Erbitux) has demonstrated activity in patients with epidermal growth factor receptor (EGFR) expressing colorectal cancer (CRC) refractory to irinotecan (CPT-11) both as a single agent and in combination with irinotecan. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b6b8b1cdec77632b885caa4109a5f00
https://doi.org/10.1200/jco.2004.22.90140.3510
https://doi.org/10.1200/jco.2004.22.90140.3510